1. Home
  2. BWA vs QGEN Comparison

BWA vs QGEN Comparison

Compare BWA & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BorgWarner Inc.

BWA

BorgWarner Inc.

HOLD

Current Price

$44.99

Market Cap

9.2B

ML Signal

HOLD

Logo Qiagen N.V.

QGEN

Qiagen N.V.

HOLD

Current Price

$45.37

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWA
QGEN
Founded
1987
1986
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
10.2B
IPO Year
1993
1996

Fundamental Metrics

Financial Performance
Metric
BWA
QGEN
Price
$44.99
$45.37
Analyst Decision
Buy
Buy
Analyst Count
14
7
Target Price
$46.93
$49.74
AVG Volume (30 Days)
2.8M
1.2M
Earning Date
10-30-2025
02-04-2026
Dividend Yield
1.53%
3.34%
EPS Growth
N/A
331.20
EPS
0.61
1.84
Revenue
$14,183,000,000.00
$2,070,781,000.00
Revenue This Year
$2.00
$7.12
Revenue Next Year
$2.43
$6.13
P/E Ratio
$72.92
$24.59
Revenue Growth
0.10
5.32
52 Week Low
$24.40
$37.63
52 Week High
$46.39
$51.88

Technical Indicators

Market Signals
Indicator
BWA
QGEN
Relative Strength Index (RSI) 58.04 42.07
Support Level $41.63 $44.82
Resistance Level $45.51 $47.48
Average True Range (ATR) 0.81 0.60
MACD 0.22 -0.18
Stochastic Oscillator 85.29 11.11

Price Performance

Historical Comparison
BWA
QGEN

About BWA BorgWarner Inc.

BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2024, 23% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Share on Social Networks: